USA Centers for Disease Control (CDC) news (including ME/CFS Stakeholder Engagement and Communication Calls) - next call 4 Dec 2024

CDC ME/CFS Program Update has just been posted in advance of today's meeting
https://www.cdc.gov/me-cfs/pdfs/23-sec-cdc-program-update-5-3-24.pdf
Recently released information on CDC ME/CFS Stakeholder call

Slides [for "Clinical Manifestations and pathophysiology of #LongCOVID" by Avi Nath]
https://www.cdc.gov/me-cfs/pdfs/23-sec-call-covid-cdc-slides-508.pdf

Transcript
https://www.cdc.gov/me-cfs/media/pdfs/2024/06/23-SEC_-May-6-2024_-Transcript_-FINAL.pdf

 
Source: CDC
MECFS-SEC
Date: October 16, 2024
Author: Dana Brimmer
URL: mailto:MECFSSEC@cdc.gov


CDC ME/CFS Call December 4, 2024 3:00pm ET
------------------------------------------
CDC ME/CFS Stakeholder Engagement and Communication (SEC) Conference
Call.

Participants can join the call using zoom by clicking on the Link OR
copying and pasting it into your web browser.

Participants can join the zoom webinar by clicking this link:
https://cdc.zoomgov.com/j/1612754572?pwd=EPxMfvWuzHjEbrPF1kZ2SHFFwksqjo.1
When the zoom page opens,
* click on the 'launch meeting' button,
* enter your email address and name, then
* click on the 'join webinar' button.

Participants can also join by phone using the following number (when
prompted, please enter the meeting id and passcode):
* TELEPHONE: 1-669-254-5252
* MEETING ID: 161 275 4572
* PASSCODE: 12116411


Meeting Agenda
--------------

Welcome and Meeting Overview

Updates from CDC
Elizabeth Unger, PhD, MD
Branch Chief, Chronic Viral Diseases Branch, Centers for Disease Control
and Prevention

'A Primer About POTS'
Satish Raj, M.D.
Professor of Cardiac Science, Libin Cardiovascular Institute and the
University of Calgary's Cumming School of Medicine, University of
Calgary, Canada

Question and Answer (Q&A)
To ask a question during the meeting within the Zoom webinar platform,
please:
* Click on the 'Raise Hand' button.
* Ask your question when prompted.
To ask a question during the meeting by phone, please:
* Enter *9 to add yourself to the queue.
* Ask your question when prompted.

Closed captioning will be provided the week before the call.

More information about CDC SEC Calls can be found at the CDC ME/CFS
website.

https://www.cdc.gov/me-cfs/events/?CDC_AAref_Val=https://www.cdc.gov/me-cfs/programs/meetings.html

 
Last edited:
Source: CDC
MECFS-SEC
Date: October 16, 2024
Author: Dana Brimmer
URL: mailto:MECFSSEC@cdc.gov


CDC ME/CFS Call December 4, 2024 3:00pm ET
------------------------------------------
CDC ME/CFS Stakeholder Engagement and Communication (SEC) Conference
Call.

Participants can join the call using zoom by clicking on the Link OR
copying and pasting it into your web browser.

Participants can join the zoom webinar by clicking this link:
https://cdc.zoomgov.com/j/1612754572?pwd=EPxMfvWuzHjEbrPF1kZ2SHFFwksqjo.1
When the zoom page opens,
* click on the 'launch meeting' button,
* enter your email address and name, then
* click on the 'join webinar' button.

Participants can also join by phone using the following number (when
prompted, please enter the meeting id and passcode):
* TELEPHONE: 1-669-254-5252
* MEETING ID: 161 275 4572
* PASSCODE: 12116411


Meeting Agenda
--------------

Welcome and Meeting Overview

Updates from CDC
Elizabeth Unger, PhD, MD
Branch Chief, Chronic Viral Diseases Branch, Centers for Disease Control
and Prevention

'A Primer About POTS'
Satish Raj, M.D.
Professor of Cardiac Science, Libin Cardiovascular Institute and the
University of Calgary's Cumming School of Medicine, University of
Calgary, Canada

Question and Answer (Q&A)
To ask a question during the meeting within the Zoom webinar platform,
please:
* Click on the 'Raise Hand' button.
* Ask your question when prompted.
To ask a question during the meeting by phone, please:
* Enter *9 to add yourself to the queue.
* Ask your question when prompted.

Closed captioning will be provided the week before the call.

More information about CDC SEC Calls can be found at the CDC ME/CFS
website.

https://www.cdc.gov/me-cfs/events/?CDC_AAref_Val=https://www.cdc.gov/me-cfs/programs/meetings.html
This is on in less than 24 hours wherever you are in the world.

 
(Thanks. I was joining from my browser, as I hadn't updated my zoom version, and with that the screen asking for the passcode appeared. When I updated my zoom version the screen asking for a passcode did not appear. It's odd as the Cdc did provide a passcode, it just didn't work.)
 
Last edited:
I was doing something else while listening, so I don't have much in the way of notes.

On the CDC update, I missed that, so I'm just going off the pdf provided before the meeting. At 5 pages, it's not so long to read but here's a summary and some comments on some interesting things there:
I would like to welcome Joanna Regan, as our new medical officer and team lead working on ME/CFS. Joanna is trained as a pediatrician and also has a master’s in public health. She came to work at CDC in 2009 in the Rickettsial Zoonoses Branch as a medical officer. Her past work at CDC has included investigations on an outbreak of Rocky Mountain spotted fever, and on Ebola and Middle East Respiratory Syndrome. She has worked with health departments and traveled tomore than 20 countries for CDC. We are excited to have Joanna as part of CDC’s ME/CFS program.
A new person in the CDC ME/CFS team. That's an interesting background, with rickettsias, Ebola and MERS all implicated in the triggering of ME/CFS.



As part of the CDC's educational programme, they had an event for nursing students at the Emory School of Nursing which they organised in conjunction with MEAction Georgia. While the event sounds good, but the scale of effort seems off by an order of magnitude. I don't know if the session was recorded?



We are thrilled to announce that an extensive collection of more than 70 datasets and biospecimens from MCAM are now accessible through the websites mapMECFS and searchMECFS, respectively. Applications for data use and biospecimens are approved through data use agreements.
MCAM = Multi-site Clinical Assessment of ME/CFS study
I can't recall what we have thought about the study, but a biobank and databank available to researchers sounds like a good initiative.
More from the MCAM study:
we published “Chronic Overlapping Pain Conditions in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Sample from the Multi-Site Clinical Assessment of ME/CFS (MCAM) Study,” and “Cognitive Assessment in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Cognitive Sub-study of the Multi-Site Clinical Assessment of ME/CFS (MCAM)
75% of people with ME/CFS had at least one of the following chronic overlapping pain conditions: chronic low back pain, chronic migraines or headaches, fibromyalgia, interstitial cystitis or irritable bowel syndrome, or temporomandibular disorder.
In the cognitive study, we found processing speed was significantly lower for people with ME/CFS when compared to healthy controls. We also found that the challenges associated with a clinic visit that includes cognitive testing worsened processing speed to the same extent as exercise testing.
Those findings about cognition are very interesting - I'll link the studies if I can find them. Edit - Here it is:
Cognitive assessment in ME/CFS: a cognitive substudy of the multi-site clinical assessment of ME/CFS (MCAM), 2024, Lange, Unger +


National Association of School Nurses
CDC has a contract with the NASN, and here it does seem as though there is a good level of effort in educating medical professionals. They say they have reached 40,000 school nurses with educational materials during the 3 year NASN partnership, and 11,000 school nurses have undertaken CPD on ME/CFS in the past year.
Additionally, we have tracked absences for over 15,000 students, identifying that approximately 3% were due to ME/CFS-related symptoms. In October, we began the next phase and aim to expand our data collection efforts across eight more states.


ICUE
In October, we wrapped up our partnership project, “Infection-Associated Chronic Conditions— Understanding and Engagement,” also known as ICUE.
...CDC Foundation’s lead partner organizations, Solve M.E., the COVID-19 Longhauler Advocacy Project, and the Patient-Led Research Collaborative hosted the final webinar
This seems to have involved some webinars, and some collaboration with patient organisations.



STOP ME/CFS project
CDC is working with the Emerging Infections Program in California and Kaiser Permanente Northern California. Work on quantifying the incidence of ME/CFS has been published. The study is ongoing.
Overall, the researchers estimated that 1.67%, or 45,892, of 2.7 million adult KPNC members of the Kaiser plan in Northern California had ME/CFS-like syndrome during the study period, which was July to October 2022. Of those, 14% developed the illness after COVID-19.


Long COVID and Fatiguing Illness Recovery Program
We are also continuing our work to educate primary care providers about Long COVID, ME/CFS and other post-acute infection syndromes through the Long COVID and Fatiguing Illness Recovery Program. This project is a collaboration with one of the largest federally qualified health centers, the Family Health Centers of San Diego, along with the ECHO Institute at the University of New Mexico, and the Schools of Medicine at the University of Washington, and the University of Colorado. In this third year of the program, our collaborators have continued to host monthly webinars for continuing medical education credit. From the program’s inception, the webinars have included presentations and discussion by both medical and lived experience experts (meaning either a patient or patient caregiver). In the past 6 months, webinars have covered recent research findings and other topics such as the diagnosis of post-exertional malaise and Long COVID Patient Navigation. Beginning November 7, the program expanded the opportunity to enroll in monthly case-consultation and mentoring through the ECHO online platform to primary care clinicians nationwide. On November 14, the program’s 10th online short course for CME credit, called “Long COVID in Children and Adolescents,” was posted.
I copied that out in full. It sounds positive. Of course, it depends a lot on what the webinars are saying, but at least they are mentioning post-exertional malaise. I wonder why the CDC hasn't focussed on improving medical training i.e. getting the doctors and nurses informed before they face patients. I wonder how big that primary care clinician support program (ECHO) is.

COVID-RELIEF Project
Finally, in early November, we published a paper resulting from the COVID-RELIEF Project, our collaboration with the University of Washington, in BMC Infectious Diseases.The paper describes quality of life impairments and subjective cognitive decline associated with Long COVID two or more years after the patients’ initial SARS-CoV-2 infection.

My sense is of some reasonable initiatives, but it's all very piecemeal, small and preliminary. Also, a lot of things that are Long Covid are now being counted as ME/CFS effort. Which is fair enough I guess, but the combined effort surely needs to be much bigger than this. Where is the national effort on accurate coding so that the size of the problem can really be seen? Where is the CDC's effort to prevent more people getting LC-ME/CFS?

If anyone from the CDC reads this, it would be great if they could include hyperlinks to the research and webinars that they mention in their pre-meeting transcript. It would save people a lot of time hunting around for research, given that they often don't give very good identifying information.
 
Last edited:
On Dr Satish Raj's presentation:

Now I'd like to introduce our guest speaker. Dr. Satish Raj is a Heart Rhythm Cardiologist. He completed his internal medicine and cardiology training at Queen’s University, and then further trained in cardiac electrophysiology at the University of Calgary. He then spent 12 years working at the Vanderbilt Autonomic Dysfunction Center in Nashville, Tennessee. He is currently Professor of Cardiac Science at the Libin Cardiovascular Institute and the University of Calgary’s Cumming School of Medicine and founder of the Calgary Autonomic Investigation & Management Clinic. His primary research interests relate to understanding and better treating postural tachycardia syndrome (POTS), vasovagal syncope, and orthostatic hypotension. He is conducting studies into the role of autoantibodies and inflammation in POTS and understanding the “brain fog” of POTS. He is also looking at repurposing drugs in novel ways to treat vasovagal syncope and orthostatic hypotension. Welcome, Dr. Raj.

It was an interesting presentation. I think it's worth a listen by anyone interested in orthostatic intolerance in ME/CFS. He comes across as trying his best for his patients, and engaging in research to try to answer questions about treatments.

Dr Raj distinguished POT(the symptom) from POTS (the syndrome). He notes that POT occurs in most people when they have a viral infection. I think that's a really interesting observation. Why does that happen? Is it part of the engineered sickness response, to get people fighting an infection to stop, lie down and direct energy resources to getting well? How does it work?

He also notes that fatigue tends to be ubiquitous in people presenting with POTS, even if they don't meet ME/CFS criteria.

He said that POTS isn't really a fainting disorder, people just feel very unwell. He said that in a recent tilt table test study, more POTS patients completed the test than controls did. They felt really bad, but they didn't faint, perhaps because the tachycardia was compensating/responding to the physiological challenge.

There was an interesting section on whether patients with POTS are more anxious than normal. Dr Raj's wife is a psychiatrist and she she looked at this question. She found that the POTS patients were more anxious than the healthy controls, but they weren't more anxious than the population in general. She found that the healthy controls in the study were actually hyper-mentally well (or I guess at least reported being so). It could be worth finding that study, Raj et al 2009. It's a good point to remember - there is selection bias in the controls as well as the patients.

Dr Raj noted that a diagnosis of POTS is like a diagnosis of a fever - lots of causes, and the right treatment depends on the cause. Doctors should be trying to find the cause.

Okamoto 2012 study - looked at the overlap of POTS and ME/CFS - and found a substantial overlap.

Garland 2012 study - looked at the effect of salt. Dr Raj says that the study found that a high sodium diet did increase plasma volume, reduced plasma norepinephrine and decreased standing heart rate. There was a trend to reduced symptoms. He recommends it to his patients.

Bourne et al 2021 and a new one Bourne et al 2024 - looked at the effect of compression garments. Found they do work, especially garments that compress the abdomen, where most of the blood pooling occurs.

He also mentions exercise as useful, especially recumbent exercise. And also that there are medications.

He says that all of these are management tools that can help, even perhaps help a lot, but they are not cures.
 
Last edited:
He said that POTS isn't really a fainting disorder, people just feel very unwell. He said that in a recent tilt table test study, more POTS patients completed the test than controls did. They felt really bad, but they didn't faint, perhaps because the tachycardia was compensating/responding to the physiological challenge.
Maybe because patients have had experience with and practice at managing POTS? They are better at reading the somatic signs, and judging how far they can push it before needing to sit/lie down?
 
Thanks Hutan, those were interesting comments. Eg the controls being uber-controls and not representative of the general population; the fact that controls would faint far more often than POTS patients (who felt terrible but were compensating); and the compression-wear being effective at the abdomen, not the lower limbs.

I'll post some of those papers you mentioned in a bit.

Edit: we had most, here are the thread links —

A Community-Based Trial of Commercially Available Compression Tights in Patients With Postural Orthostatic Tachycardia Syndrome (2024, Clinical Electrophysiology)

Compression Garment Reduces Orthostatic Tachycardia and Symptoms in Patients With Postural Orthostatic Tachycardia Syndrome (2021, Journal of the American College of Cardiology)

Salt supplementation in the management of orthostatic intolerance: Vasovagal syncope and postural orthostatic tachycardia syndrome (2022, Autonomic Neuroscience)

Dietary sodium and health: How much is too much for those with orthostatic disorders? (2022, Autonomic Neuroscience)

Effect of High Dietary Sodium Intake in Patients With Postural Tachycardia Syndrome (2021, Journal of the American College of Cardiology)
 
Last edited:
Back
Top Bottom